Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text
BMC Psychiatry,  Clinical Article

Detke HC et al. – Patients treated acutely with olanzapine long–acting injection (LAI) showed a similar pattern of improvement to that seen historically with oral olanzapine. With the exception of injection–related adverse events, the efficacy and tolerability profile of olanzapine LAI is similar to oral olanzapine.

Methods
  • Six-week results from the olanzapine LAI study (N=404) were compared with those of 3 oral studies (study 1: olanzapine vs. haloperidol vs. placebo [N=335]; study 2: olanzapine vs. haloperidol vs. low-dose olanzapine [N=431]; study 3: olanzapine vs. placebo vs. low-dose olanzapine [N=152]).
  • All patients had baseline Brief Psychiatric Rating Scale (BPRS) scores >=24 (0-6 scale).
  • Six-week effect sizes were calculated.
  • Efficacy onset, pharmacokinetics, discontinuations, weight gain, and extrapyramidal symptoms were also assessed.

Results
  • At 6 weeks, mean BPRS scores decreased by 14 to 15 points for olanzapine LAI (405 mg/4 weeks, 210 or 300 mg/2 weeks), by 8 to 16 for oral olanzapine (10+/-2.5 or 15+/-2.5 mg/day), and by 12 to 13 for haloperidol (15+/-5 mg/day).
  • For those same dose groups, effect sizes vs. placebo for the BPRS were 0.7 to 0.8 for olanzapine LAI, 0.5 to 0.7 for oral olanzapine, and 0.6 for haloperidol.
  • The first statistically significant separation from placebo on the BPRS occurred at 3 days for the olanzapine LAI groups and at 1 week for oral olanzapine and haloperidol (15+/-5 mg/day) in oral study 1 although as late as week 6 for the 10-mg/day olanzapine dose in oral study 3.
  • Olanzapine concentrations were similar across studies.
  • Weight gain >=7% of baseline occurred in up to 35% of olanzapine LAI and oral patients versus up to 12% of haloperidol and placebo patients.
  • Extrapyramidal symptoms were lowest in the olanzapine LAI groups and significantly greater in the haloperidol groups.
  • No post-injection delirium/sedation syndrome events occurred in the olanzapine LAI study.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 17, 2014    Clinical Article

2 Levomilnacipran: A new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder Annals of Pharmacotherapy, July 28, 2014    Review Article    Clinical Article

3 Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder International Clinical Psychopharmacology, July 3, 2014    Clinical Article

4 A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression Journal of Affective Disorders, July 21, 2014    Evidence Based Medicine

5 Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: A meta-analysis of efficacy and acceptability Clinical Therapeutics, July 14, 2014    Evidence Based Medicine    Review Article

6 The effects of dehydroepiandrosterone (DHEA) in the treatment of depression and depressive symptoms in other psychiatric and medical illnesses: a systematic review Current Drug Targets, July 30, 2014    Review Article

7 Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials Australian and New Zealand Journal of Psychiatry, July 11, 2014    Clinical Article

8 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

9 Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants The Journal of Pediatrics, July 16, 2014    Clinical Article

10 Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: A nationwide register-based cohort study in Denmark CNS Drugs, June 18, 2014    Clinical Article

11 Do depression treatments reduce suicidal ideation?: The effects of CBT, IPT, pharmacotherapy, and placebo on suicidality Journal of Affective Disorders, July 24, 2014    Clinical Article

12 Efficacy and acceptability of atypical antipsychotics for the treatment of post-traumatic stress disorder: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials Psychiatry Research, July 2, 2014    Evidence Based Medicine

13 Body mass index identified as an independent predictor of psychiatric readmission The Journal of Clinical Psychiatry, July 9, 2014    Clinical Article

14 Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study European Heart Journal, July 23, 2014

15 Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder American Journal of Health-System Pharmacy, July 8, 2014    Review Article

16 Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder Journal of Affective Disorders, July 18, 2014    Evidence Based Medicine    Clinical Article

17 Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis FOCUS, June 16, 2014    Evidence Based Medicine

18 Pretreatment brain states identify likely nonresponse to standard treatments for depression Biological Psychiatry, May 23, 2014    Clinical Article

19 Parental social responsiveness and risk of autism spectrum disorder in offspring JAMA Psychiatry, July 7, 2014    Clinical Article

20 Risk factors for the onset of panic and generalised anxiety disorders in the general adult population: A systematic review of cohort studies Journal of Affective Disorders, July 15, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close